imidazole-4-carboxamide has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SW; Nuwormegbe, SA | 1 |
| Borst, AJ; Kruse, CG; Lange, JH; van der Neut, MA; van Stuivenberg, HH; van Vliet, BJ; Yildirim, M | 1 |
| Acevedo-Duncan, M; Braun, U; Farese, RV; Fields, AP; Kahn, CR; Leitges, M; Mastorides, S; Nimal, S; Sajan, MP | 1 |
3 other study(ies) available for imidazole-4-carboxamide and Disease Models, Animal
| Article | Year |
|---|---|
AMPK Activation by 5-Amino-4-Imidazole Carboxamide Riboside-1-β-D-Ribofuranoside Attenuates Alkali Injury-Induced Corneal Fibrosis.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Cornea; Disease Models, Animal; Eye Burns; Fibroblasts; Fibrosis; Humans; Immunohistochemistry; Male; Mice; Mice, Inbred BALB C | 2020 |
Probing the cannabinoid CB1/CB2 receptor subtype selectivity limits of 1,2-diarylimidazole-4-carboxamides by fine-tuning their 5-substitution pattern.
Topics: Administration, Oral; Aminoimidazole Carboxamide; Animals; Disease Models, Animal; Drug Inverse Agonism; Hypotension; Imidazoles; Mice; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Sulfones | 2010 |
Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Topics: Aminoimidazole Carboxamide; Animals; Blood Glucose; Cholesterol; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Activation; Female; Insulin; Isoenzymes; Liver; Male; Metabolic Syndrome; Mice; Mice, Knockout; Obesity; Protein Kinase C; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Triglycerides | 2012 |